The proposed Transitional Coverage for Emerging Technologies (TCET) pathway is designed to facilitate Medicare coverage for new treatments that usually need time to develop data proving their value.
The US Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have proposed a parallel review program to expedite certain Class II and Class III breakthrough ...
On June 22, 2023, the Centers for Medicare & Medicaid Services (CMS) announced its proposed “Transitional Coverage for Technologies” (TCET) pathway—the Biden administration’s highly anticipated take ...
The Centers for Medicare & Medicaid Services’ (CMS) FY 2027 Inpatient Prospective Payment System (IPPS) Proposed Rule is framed as a hospital payment update, but for many FDA-regulated companies, its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results